TARGETING OBESITY: PHARMACOLOGICAL THERAPIES, BIOCHEMICAL AND PHYSIOLOGICAL MECHANISMS AND RENAL STONE RISK – CURRENT DRUGS AND FUTURE PERSPECTIVES

Authors

  • Muhammad Nadeem Shafique Associate professor of urology. Head of the Department of Urology and Renal Transplant, Imran Idress Teaching Hospital, Daska Road, Sialkot Medical college Sialkot Author
  • Muhammad Saeed Associate Professor, Biochemistry Department, Bolan Medical College, Quetta Author
  • Nida Shafi Assistant professor, biochemistry M. Islam Medical College. Author
  • Jamil Ahmed Siddiqui Associate Professor. Dept. Of Biochemistry Loralai Medical College ,Loralai ..Balochistan. Author
  • Javeria Sarfraz Associate Professor of Pharmacology ALLAMA IQBAL MEDICAL COLLEGE LAHORE Author
  • Azhar Ijaz Associate prof. Physiology, Loralai Medical College, Loralai, Balochistan Author
  • Farah Naz Tahir Associate Professor, Biochemistry Department, Central Park Medical College, Lahore Author

DOI:

https://doi.org/10.48047/2xfvhq46

Keywords:

Obesity, Pharmacological therapies, Biochemical mechanisms

Abstract

Obesity remains a leading public health concern worldwide, contributing to various comorbidities, including type 2 diabetes, cardiovascular diseases, and metabolic syndrome. This study aims to evaluate the effectiveness and underlying biochemical mechanisms of pharmacological therapies for obesity treatment. The study focuses on currently approved anti-obesity drugs and their impact on biochemical pathways such as appetite regulation, fat metabolism, and energy expenditure. A case control study was conducted with obese subjects assigned to either drug treatment or placebo groups. The results demonstrated a statistically significant reduction in body weight in the treatment group (p < 0.05), with notable improvements in metabolic parameters including blood glucose and lipid profile. Furthermore, biochemical markers of appetite regulation and fat oxidation were significantly altered, providing insight into the molecular mechanisms underlying the efficacy of these therapies. These findings highlight the therapeutic potential of current pharmacological interventions and point to new directions for future drug development, focusing on targeting specific molecular pathways involved in obesity. The study provides a comprehensive understanding of the biochemical basis of obesity treatment and underscores the need for further research to optimize therapeutic strategies.

Downloads

Download data is not yet available.

References

Pilitsi, E., Farr, O. M., Polyzos, S. A., Perakakis, N., Nolen-Doerr, E., Papathanasiou, A. E., & Mantzoros, C. S. (2019). Pharmacotherapy of obesity: Available medications and drugs under investigation. Metabolism, 92, 170–192.

Montan, P. D., Sourlas, A., Olivero, J., Silverio, D., Guzman, E., & Kosmas, C. E. (2019). Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects. Annals of Translational Medicine, 7(16), 393.

Tiryakioğlu, P., Yılmaz, H., Demir, İ., & Yılmaz, İ. (2023). Current pharmacological approaches in obesity treatment. DAHUDER Medical Journal, 3(2), 32–48.

Setmelanotide. (2023). In Wikipedia.

Yue, K., Haokun, Y., Rong, N., Xuxiang, Z., Hongtao, Z., & Xin, N. (2025). Progress of the anti-obesity of Berberine. arXiv.

Tiryakioğlu, P., Yılmaz, H., Demir, İ., & Yılmaz, İ. (2023). Current pharmacological approaches in obesity treatment. DAHUDER Medical Journal, 3(2), 32–48.

Pilitsi, E., Farr, O. M., Polyzos, S. A., Perakakis, N., Nolen-Doerr, E., Papathanasiou, A. E., & Mantzoros, C. S. (2019). Pharmacotherapy of obesity: Available medications and drugs under investigation. Metabolism, 92, 170–192.

Montan, P. D., Sourlas, A., Olivero, J., Silverio, D., Guzman, E., & Kosmas, C. E. (2019). Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects. Annals of Translational Medicine, 7(16), 393.

Tiryakioğlu, P., Yılmaz, H., Demir, İ., & Yılmaz, İ. (2023). Current pharmacological approaches in obesity treatment. DAHUDER Medical Journal, 3(2), 32–48.

Setmelanotide. (2023). In Wikipedia.

Yue, K., Haokun, Y., Rong, N., Xuxiang, Z., Hongtao, Z., & Xin, N. (2025). Progress of the anti-obesity of Berberine. arXiv.

Tiryakioğlu, P., Yılmaz, H., Demir, İ., & Yılmaz, İ. (2023). Current pharmacological approaches in obesity treatment. DAHUDER Medical Journal, 3(2), 32–48.

Pilitsi, E., Farr, O. M., Polyzos, S. A., Perakakis, N., Nolen-Doerr, E., Papathanasiou, A. E., & Mantzoros, C. S. (2019). Pharmacotherapy of obesity: Available medications and drugs under investigation. Metabolism, 92, 170–192.

Montan, P. D., Sourlas, A., Olivero, J., Silverio, D., Guzman, E., & Kosmas, C. E. (2019). Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects. Annals of Translational Medicine, 7(16), 393.

Tiryakioğlu, P., Yılmaz, H., Demir, İ., & Yılmaz, İ. (2023). Current pharmacological approaches in obesity treatment. DAHUDER Medical Journal, 3(2), 32–48.

Setmelanotide. (2023). In Wikipedia.

Yue, K., Haokun, Y., Rong, N., Xuxiang, Z., Hongtao, Z., & Xin, N. (2025). Progress of the anti-obesity of Berberine. arXiv.

Tiryakioğlu, P., Yılmaz, H., Demir, İ., & Yılmaz, İ. (2023). Current pharmacological approaches in obesity treatment. DAHUDER Medical Journal, 3(2), 32–48.

Pilitsi, E., Farr, O. M., Polyzos, S. A., Perakakis, N., Nolen-Doerr, E., Papathanasiou, A. E., & Mantzoros, C. S. (2019). Pharmacotherapy of obesity: Available medications and drugs under investigation. Metabolism, 92, 170–192.

Montan, P. D., Sourlas, A., Olivero, J., Silverio, D., Guzman, E., & Kosmas, C. E. (2019). Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects. Annals of Translational Medicine, 7(16), 393

Downloads

Published

2022-12-31

Issue

Section

RESEARCH ARTICLE

How to Cite

Shafique, M. N. ., Saeed, M. ., Shafi, N. ., Siddiqui , J. A. ., Sarfraz, J. ., Ijaz, A. ., & Tahir, F. N. . (2022). TARGETING OBESITY: PHARMACOLOGICAL THERAPIES, BIOCHEMICAL AND PHYSIOLOGICAL MECHANISMS AND RENAL STONE RISK – CURRENT DRUGS AND FUTURE PERSPECTIVES. History of Medicine, 8(2), 826-835. https://doi.org/10.48047/2xfvhq46